SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
罗杨
Lv1
1
20 积分
2024-03-27 加入
最近求助
最近应助
互助留言
FCRL5 regulates innate-like B cell natural antibody production and T cell-independent responses (IRM10P.607)
3小时前
求助中
Dawn of CAR-T cell therapy in autoimmune diseases
2天前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
3天前
已完结
CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients
4天前
已关闭
Autologous CD19-Targeted Chimeric Antigen Receptor (CAR)T-Cells as the Future of Systemic Lupus Erythematosus Treatment
4天前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
5天前
已完结
Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice
12天前
已完结
Optimization of current and future therapy for autoimmune diseases
12天前
已完结
Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study
16天前
已完结
RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
17天前
已完结
没有进行任何应助
感谢
30天前
感谢您的求助,对我帮助很大
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论